Physician profile
Neha Korde
NPI 1962664219
$18,950.23
in general payments reported to CMS, 2019-2025
15 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.11 · 2020: $2,750 · 2022: $4,239 · 2023: $9,688 · 2024: $304 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $541 · Education: $1.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,337.50 |
| Food and Beverage | $540.86 |
| Education | $1.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14,092.26 | 2019-2024 | Darzalex, Carvykti, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $2,750.00 | 2020 | |
| Janssen Scientific Affairs, LLC | $1,729.32 | 2022-2025 | |
| Adaptive Biotechnologies Corporation | $157.58 | 2022-2025 | Clonoseq |
| Genzyme Corporation | $144.41 | 2025 | |
| Pfizer INC. | $51.66 | 2024 | |
| Current Health, INC. | $25.00 | 2024 |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Korde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.